K-numberK252342
Device nameElectric Breast Pump (YM-8807, YM-8805, YM-8806, YM-8810)
ApplicantGuangdong Youmeng Electrical Technology Co., Ltd.
Product codeHGX
Device classClass II
Decision dateDec 19, 2025
DecisionSubstantially Equivalent
Regulation884.5160
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Electric Breast Pump (models YM-8807, YM-8805, YM-8806, YM-8810) is a powered device intended to express milk from lactating women's breasts for collection. It is a reusable, single-user device for home healthcare use that stimulates lactation by creating a seal around the nipple and applying/releasing suction via a microprocessor-controlled diaphragm pump.

Technological characteristics

The subject device differs from the predicate (K211024) in suction strength ranges (subject: -80 to -280 mmHg vs. predicate: -60 to -285 mmHg), cycle speed ranges (subject: 5–120 cycles/min vs. predicate: 14–123 cycles/min), number of suction levels (subject: 9 levels for all modes vs. predicate: 5–7 levels depending on mode), and user interface design (subject: four buttons and LED display vs. predicate: controls on pump with LED/LCD). Both use 3.7V lithium-ion batteries, diaphragm pumps, microcontrollers, and support single/double pumping with backflow protection.

Test standards cited

IEC 60601-1:2005/AMD2:2020 (electrical safety); IEC 60601-1-2:2020 (electromagnetic compatibility); IEC 60601-1-11:2020 (home healthcare environment); IEC 62133-2:2017 (lithium battery safety); ISO 10993-5:2009 (cytotoxicity); ISO 10993-23:2021 (skin irritation); ISO 10993-10:2021 (skin sensitization); 2023 FDA guidance on device software functions.

Substantial equivalence argument

The subject and predicate devices share identical indications for use, regulatory classification (Class II, 21 CFR 884.5160), and fundamental operating principles (diaphragm pump, microcontroller, single user, lactation expression). Although suction modes, strength ranges, cycle speeds, suction levels, and user interface differ, these differences do not raise different questions of safety and effectiveness. Non-clinical testing demonstrates the subject device meets all design specifications and performance acceptance criteria, supporting substantial equivalence.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →